List of Flolipid drug patents

Flolipid is owned by Tcg Fluent Pharma.

Flolipid contains Simvastatin.

Flolipid has a total of 2 drug patents out of which 0 drug patents have expired.

Flolipid was authorised for market use on 21 April, 2016.

Flolipid is available in suspension;oral dosage forms.

The generics of Flolipid are possible to be released after 23 February, 2030.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10300041 TCG FLUENT PHARMA Liquid oral simvastatin compositions
Apr, 2027

(4 years from now)

US9597289 TCG FLUENT PHARMA Liquid oral simvastatin compositions
Feb, 2030

(7 years from now)

Drugs and Companies using SIMVASTATIN ingredient

Market Authorisation Date: 21 April, 2016

Treatment: NA

Dosage: SUSPENSION;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic